The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
Apple bought Tueo Health, which was developing tech to help parents monitor asthma symptoms in children, using a mobile app and commercial breathing sensors.Technologyread more
United Airlines will take its 14 Boeing 737 Max jets off its schedule for another month, through Aug. 3, canceling another 1,290 flights.Airlinesread more
Trade could be a big factor for markets in the week ahead, but investors will also be attuned to fresh inflation data and the bond market, which is flashing new worries about...Market Insiderread more
Mississippi is one of several states that have moved to pass new restrictions on abortion this year.Politicsread more
SHANGHAI, Nov 29 (Reuters) - The organizers of a conference where a Chinese scientist claimed to have edited the genes of twin babies condemned the work on Thursday, calling it "deeply disturbing" and "irresponsible."
"Even if the modifications are verified, the procedure was irresponsible and failed to conform with international norms," the organizing committee of the Second International Summit on Human Genome Editing, being held in Hong Kong this week, said in a statement released by email and posted online.
The statement called for an independent assessment of Chinese scientist He Jiankui's claims on Wednesday that he used a gene-editing technology known as CRISPR-Cas9 to alter the embryonic genes of twin girls born this month.
He's announcement, which has not been verified, sparked an international outcry about the ethics and safety of such research.
Chinese scientists have condemned the work. Southern University of Science and Technology, where He is on leave from his position as an associate professor, has announced an investigation.
The Guangdong province Health Commission said on its website on Wednesday it and Shenzhen city had set up a team to investigate the case. He's filing to a Chinese clinical trials database indicates that a hospital did an ethical review of the project, but the hospital involved denied that its ethics review committee ever met to discuss the work.
He said after his presentation on Wednesday he was proud of what he had done.
The presidents of the U.S. National Academy of Sciences (NAS) and the U.S. National Academy of Medicine (NAM) also expressed concern about He's work. Their statement was emailed on Thursday but dated on Tuesday.
"The events in Hong Kong this week clearly demonstrate the need for us to develop more specific standards and principles that can be agreed upon by the international scientific community," NAS president Marcia McNutt and NAM president Victor Dzau wrote.
(Reporting By Alexandra Harney Editing by Paul Tait)